Thyroid Eye Disease
-
{
- All
- News
-
Bulging Eye Disease Cases Rising Among Women Over 40: Report
Thyroid Eye Disease (TED) is increasingly affecting women over 40, causing bulging eyes and potentially leading to sight loss.
-
First Treatment For Thyroid Eye Disease Approved By US FDA
The drug, Tepezza (teprotumumab-trbw), was approved based on the results of two studies consisting of a total of 170 patients with active thyroid eye disease who were randomised to either receive Tepezza or a placebo.
-
First Treatment For Thyroid Eye Disease Approved By US FDA
The drug, Tepezza (teprotumumab-trbw), was approved based on the results of two studies consisting of a total of 170 patients with active thyroid eye disease who were randomised to either receive Tepezza or a placebo.
-
Bulging Eye Disease Cases Rising Among Women Over 40: Report
Thyroid Eye Disease (TED) is increasingly affecting women over 40, causing bulging eyes and potentially leading to sight loss.
-
First Treatment For Thyroid Eye Disease Approved By US FDA
The drug, Tepezza (teprotumumab-trbw), was approved based on the results of two studies consisting of a total of 170 patients with active thyroid eye disease who were randomised to either receive Tepezza or a placebo.
-
First Treatment For Thyroid Eye Disease Approved By US FDA
The drug, Tepezza (teprotumumab-trbw), was approved based on the results of two studies consisting of a total of 170 patients with active thyroid eye disease who were randomised to either receive Tepezza or a placebo.
